
Free Daily Podcast Summary
by Verpora
Unscripted conversations with the people shaping drug pricing, access, and reimbursement around the world.Hosted by Omar Ali, Head of Payers at Verpora, The Payer Exchange brings you honest, off-the-record discussions with payers working at the frontline of healthcare funding. Each episode features a one-to-one conversation with a payer from a different country—exploring local challenges, emerging trends, and contrasting approaches to some of the biggest questions in market access.From horizon scanning to contracting, rare disease to real-world evidence, we ask the same core questions—but get different answers every time.This isn’t a panel. It’s not a pitch. It’s a rare chance to hear what really drives decision-making—direct from those making the decisions.
The most recent episodes — sign up to get AI-powered summaries of each one.
Continuing the US-focused series, Omar Ali speaks with Matt Harman, VP of Clinical Solutions at Employers Health, bringing an employer-sponsored health plan perspective to questions of affordability, access and benefit sustainability. They discuss commercial spillover from Medicare reforms, specialty pipeline risk, medical benefit visibility, biosimilars, GLP-1 affordability and the changing role of Pharmacy Benefit Managers (PBM)s. Matt explains how Employers Health works with self-insured e...
In Episode 12, Omar Ali speaks with Drake Reiter, Director of Pharmacy Operations at Priority Health, about how a regional US health plan is thinking about the next phase of pricing and contracting reform. They discuss Most Favoured Nation (MFN), the Inflation Reduction Act (IRA) and Pharmacy Benefit Manager (PBM) reform, the gradual erosion of rebate-led contracting, commercial spillover from Medicare Most Fair Pricing (MFPs), transparency, formulary leverage and whether a different definiti...
Launching Series 3 of The Payer Exchange’s special US focus, Omar Ali speaks with Jill Hanson, VP of Regional Pharmacy at Centene Pharmacy Services, who brings a specialty pharmacy perspective to changes in drug pricing, contracting and medical benefit management, from one of the largest Medicaid managed care organisations in the US. The conversation covers MFN, GUARD and GLOBE, the shift away from rebate maximisation, high-cost therapy forecasting, Part B pricing and site-of-care opti...
What happens when the world’s largest pharmaceutical market fundamentally changes the way it pays for medicines? As US policy evolves around Most Favoured Nation pricing, the Inflation Reduction Act, CMS drug price negotiations and international reference pricing, the consequences could influence launch sequencing, commercial strategy and patient access around the world. Season 3 of The Payer Exchange has a special US focus, bringing together complementary perspectives from specialty pharmacy...
In the final episode of the series, Omar speaks with Dr Abdulrazag Al-Jazairi, Advisor to the Saudi Food and Drug Authority, about the rapidly evolving payer and HTA environment in Saudi Arabia. They discuss what it means to develop payer infrastructure from the ground up, the influence of international frameworks on domestic decision-making, and how value-based agreements are beginning to play a role in national pricing strategy. Key themes: HTA system development in Saudi ArabiaLocal adapta...
In this episode, Omar speaks with Canadian health economist and policy advisor Don Husereau about Canada’s unique payer landscape. Don isn’t your typical policy analyst. He’s worked in HTA, advised governments, and written widely about the gaps, flaws, and hidden logic in pricing systems like Canada’s. They discuss the decentralised nature of decision-making, the gap between evidence generation and clinical practice, and the disconnect between how healthcare science is developed versus ...
Omar is joined by Professor Lieven Annemans, former chair of Belgium’s health economics advisory committee, to explore the complexities of European HTA policy. They talk about the role of Joint Clinical Assessment (JCA), the risk of over-assessment in policy design, and the challenge of maintaining local relevance within a harmonised EU framework. Lieven brings perspective on how the purpose of assessment is sometimes lost in the process of implementation. Key themes: Joint Clinical Assessmen...
Omar speaks with Dr Krzysztof Łanda, former Deputy Minister of Health, health economist, and someone who’s helped shape the pricing and HTA landscape in Poland over the past two decades. They examine the influence of external pricing references, the practical realities of MFN implementation, and the state of HTA reform. The discussion also covers the potential role of JCA and how manufacturers can adapt to a system that combines political oversight with economic rigor. Key themes: External re...
Unscripted conversations with the people shaping drug pricing, access, and reimbursement around the world.Hosted by Omar Ali, Head of Payers at Verpora, The Payer Exchange brings you honest, off-the-record discussions with payers working at the frontline of healthcare funding. Each episode features a one-to-one conversation with a payer from a different country—exploring local challenges, emerging trends, and contrasting approaches to some of the biggest questions in market access.From horizon scanning to contracting, rare disease to real-world evidence, we ask the same core questions—but get different answers every time.This isn’t a panel. It’s not a pitch. It’s a rare chance to hear what really drives decision-making—direct from those making the decisions.
AI-powered recaps with compact key takeaways, quotes, and insights.
Get key takeaways from The Payer Exchange in a 5-minute read.
Stay current on your favorite podcasts without falling behind.
It's a free AI-powered email that summarizes new episodes of The Payer Exchange as soon as they're published. You get the key takeaways, notable quotes, and links & mentions — all in a quick read.
When a new episode drops, our AI transcribes and analyzes it, then generates a personalized summary tailored to your interests and profession. It's delivered to your inbox every morning.
No. Podzilla is an independent service that summarizes publicly available podcast content. We're not affiliated with or endorsed by Verpora.
Absolutely! The free plan covers up to 3 podcasts. Upgrade to Pro for 15, or Premium for 50. Browse our full catalog at /podcasts.
The Payer Exchange publishes daily. Our AI generates a summary within hours of each new episode.
The Payer Exchange covers topics including Science, Government, Medicine, Fitness, Health & Fitness, Life Sciences. Our AI identifies the specific themes in each episode and highlights what matters most to you.
Free forever for up to 3 podcasts. No credit card required.
Free forever for up to 3 podcasts. No credit card required.